Is Puma Biotechnology, Inc. overvalued?

Puma Biotechnology, Inc. (PBYI) looks overvalued — trading about 35% above its fair value.

Overvalued

Price

$8.83

Fair value

$5.77

Current P/E

14.5

Normal P/E

9.5

Market cap

$449.4M

Dividend yield

0.0%

Return on equity

20.9%

Sector

Healthcare

Fair value compares PBYI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks